{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:30:14Z","timestamp":1740126614840,"version":"3.37.3"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,16]]},"DOI":"10.1093\/eurheartj\/ehae070","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T08:52:00Z","timestamp":1708159920000},"page":"491-494","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Centre of Excellence of Cardiovascular Sciences, Gemelli Isola Hospital , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"2024021708515736500_ehae070-B1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad837","article-title":"The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias","volume":"45","author":"Tokgozoglu","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B2","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad878","article-title":"The year in cardiovascular medicine 2023: the top 10 papers in heart failure and cardiomyopathies","volume":"45","author":"Bauersachs","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B3","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad572","article-title":"Atrial fibrillation progression after cryoablation versus radiofrequency ablation: the CIRCA-DOSE trial","volume":"45","author":"Andrade","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B4","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1093\/eurheartj\/ehad615","article-title":"Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition","volume":"44","author":"Wang","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/eurheartj\/ehad508","article-title":"Stroke risk in women with atrial fibrillation","volume":"45","author":"Buhari","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B6","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad556","article-title":"New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry","volume":"45","author":"Gautier","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B7","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1093\/eurheartj\/ehad571","article-title":"Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation","volume":"44","author":"Wu","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B8","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/eurheartj\/ehad375","article-title":"New-onset atrial fibrillation prediction: the HARMS2-AF risk score","volume":"44","author":"Segan","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B9","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/eurheartj\/ehad396","article-title":"Histological validation of atrial structural remodelling in patients with atrial fibrillation","volume":"44","author":"Takahashi","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad872","article-title":"Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?","volume":"45","author":"Younes","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B11","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad771","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes \u226524 hours","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehad200","article-title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B13","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1093\/eurheartj\/ehac587","article-title":"Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing","volume":"43","author":"Meyre","year":"2022","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B14","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/eurheartj\/ehac111","article-title":"Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study","volume":"43","author":"Komen","year":"2022","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/eurheartj\/ehad123","article-title":"Reversal agents for current and forthcoming direct oral anticoagulants","volume":"44","author":"van Es","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B16","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad798","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks","volume":"45","author":"Kanaoka","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B17","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad874","article-title":"Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification","volume":"45","author":"Brienesse","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B18","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/eurheartj\/ehad086","article-title":"Phosphodiesterase 8 governs cAMP\/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism","volume":"44","author":"Grammatika Pavlidou","year":"2023","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B19","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1093\/eurheartj\/ehac485","article-title":"Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy","volume":"43","author":"Smedsrud","year":"2022","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B20","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/eurheartj\/ehac289","article-title":"Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator","volume":"43","author":"Jord\u00e0","year":"2022","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B21","doi-asserted-by":"crossref","first-page":"e1-9","DOI":"10.1093\/eurheartj\/ehac180","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"43","author":"Cadrin-Tourigny","year":"2022","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B22","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad799","article-title":"Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae022","article-title":"Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy","volume":"45","author":"Elliott","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad805","article-title":"Randomized controlled trials are not always the solution","volume":"45","author":"Finocchietti","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/eurheartj\/ehad567","article-title":"Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium","volume":"45","author":"Siontis","year":"2024","journal-title":"Eur Heart J"},{"key":"2024021708515736500_ehae070-B26","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad806","article-title":"Randomized controlled trials remain underutilized","volume":"45","author":"Siontis","year":"2024","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/7\/491\/56690653\/ehae070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/7\/491\/56690653\/ehae070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T19:01:15Z","timestamp":1731351675000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/7\/491\/7609331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,2,16]]},"published-print":{"date-parts":[[2024,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae070","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2024,2,14]]},"published":{"date-parts":[[2024,2,14]]}}}